Gary Goldenberg, MD, Mount Sinai School of Medicine — New York, New York

Gary Goldenberg, MD, Mount Sinai School of Medicine is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Gary Goldenberg, MD, Mount Sinai School of Medicine has participated in 1 clinical trials.

Therapeutic areas: Active Plaque Psoriasis.

Sponsors: Vascular Biogenics Ltd. operating as VBL Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gary Goldenberg, MD, Mount Sinai School of Medicine?

Gary Goldenberg, MD, Mount Sinai School of Medicine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gary Goldenberg, MD, Mount Sinai School of Medicine conducted?

Gary Goldenberg, MD, Mount Sinai School of Medicine has 1 clinical trials on record. Their work covers Active Plaque Psoriasis.

Is Gary Goldenberg, MD, Mount Sinai School of Medicine accredited by Crixeo Health?

Gary Goldenberg, MD, Mount Sinai School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Gary Goldenberg, MD, Mount Sinai School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.